Annals of the Rheumatic Diseases
Academic journal
From Wikipedia, the free encyclopedia
The Annals of the Rheumatic Diseases is an international peer-reviewed medical journal. It is published by Elsevier on behalf of the European Alliance of Associations for Rheumatology and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes original research, reviews, recommendations, and various other articles, as well as abstracts from conferences.[1] The journal was established in 1939,[2] and operates under a hybrid subscription business model that enables open access.[3] The editor-in-chief is Josef Smolen.[4]
| Discipline | Rheumatology |
|---|---|
| Language | English |
| Edited by | Josef Smolen |
| Publication details | |
| History | 1939–present |
| Publisher | Elsevier on behalf of the European Alliance of Associations for Rheumatology |
| Frequency | Monthly |
| Hybrid | |
| 20.3 (2023) | |
| Standard abbreviations | |
| ISO 4 | Ann. Rheum. Dis. |
| Links | |
Change of ownership and publisher
Abstracting and indexing
The journal is abstracted and indexed in the Science Citation Index Expanded, Index Medicus, Excerpta Medica, and BIOSIS Previews.[1] According to the Journal Citation Reports, its 2023 impact factor is 20.3.[8][9]
The journal has been cited most often by: Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Rheumatology, Journal of Rheumatology, and Clinical and Experimental Rheumatology. The journals it has cited most are Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Journal of Rheumatology, Rheumatology, and Journal of Immunology.